Journal Home
Search for

Volume 136, Issue 2, Pages 93-100 (15 September 2005)


View previous. 3 of 19 View next.

Psychiatric disorders and their comorbidity in subjects with parasuicide by intentional drug overdose: Prevalence and gender differences

Marie TournierCorresponding Author Informationemail address, Mathieu Molimard, Audrey Cougnard, Abdelilah Abouelfath, Annie Fourrier, Helene Verdoux

Received 25 October 2004; received in revised form 14 April 2005; accepted 24 June 2005.

Abstract 

The aims of the present study were to assess the prevalence and comorbidity of psychiatric disorders in subjects with intentional drug overdose and to explore whether there were gender differences in prevalence and comorbidity. A standardized psychiatric evaluation was performed in 100 randomly selected subjects, 18 years old and older, with intentional drug overdose referred to an emergency department. The prevalences of psychiatric morbidity and comorbidity were very high in both genders: 88% presented with at least one psychiatric diagnosis, and three-quarters presented with comorbid psychiatric disorders. Affective and anxiety disorders were the most prevalent diagnoses. One patient out of three presented with alcohol or substance misuse. Compared to females, males suffered five times more often from substance misuse and three times more often from psychotic syndrome and were three times less likely to present with anxiety disorder. When subjects are referred to hospital for intentional drug overdose, medical management should systematically involve a psychiatric assessment in order to identify not only affective and anxiety disorders, but also alcohol and substance misuse, due to the high prevalence of these disorders, especially in male subjects.

Université Victor Segalen-Bordeaux2, INSERM U657, IFR99 of Public Health, 146 rue Léo Saignat, 33076 Bordeaux, France

Corresponding Author InformationCorresponding author. Hôpital Charles Perrens, 121 rue de la Béchade, 33076 Bordeaux cedex, France. Tel.: +33 556 56 17 32; fax: +33 556 56 35 46.

PII: S0165-1781(05)00183-6

doi:10.1016/j.psychres.2005.06.007


View previous. 3 of 19 View next.